Dosing Implications for Liposomal Amphotericin B in Pregnancy.

Niamh O'GradyMatthew DavisDayna McManusJeffrey TopalMarwan M AzarNeima Briggs

Published in: Pharmacotherapy (2023)

This review describes our experience in using ideal body weight for dosing LAmB in pregnancy for the treatment of MCL. Use of ideal body weight may minimize risk of adverse effects to the fetus compared to the use of total body weight while maintaining efficacy for treatment of MCL in pregnancy.

Keyphrases

body weight
pregnancy outcomes
combination therapy
pregnant women
smoking cessation